A 4-month, open-label, multi-center study to explore tolerability and safety and health outcomes of FTY720 in patients with relapsing forms of multiple sclerosis

Chercheur principal: 

Jean-Pierre Bouchard

Organisme subventionnaire: 

Novartis Canada Ltd

Statut: 
Projet terminé

CIUSSS-CN Université Laval Alliance santé Québec